Get the Stockscreener App
3.67
9.55%
0.32
Endra Life Sciences Inc stock is traded at $3.67, with a volume of 2.10M.
It is up +9.55% in the last 24 hours and down -10.61% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$3.35
Open:
$3.35
24h Volume:
2.10M
Relative Volume:
31.68
Market Cap:
$1.74M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-0.00531
EPS:
-691.4213
Net Cash Flow:
$-8.08M
1W Performance:
-7.09%
1M Performance:
-10.61%
6M Performance:
-49.12%
1Y Performance:
-99.09%
1-Day Range:
$3.27
$5.58
1-Week Range:
$3.02
$5.58
52-Week Range:
$3.02
$664.82
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
3.67 | 1.74M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Endra Life Sciences Inc Stock (NDRA) Latest News
NDRA stock touches 52-week low at $3.05 amid sharp annual decline By Investing.com - Investing.com South Africa
NDRA stock touches 52-week low at $3.05 amid sharp annual decline - Investing.com India
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
ENDRA Life Sciences Stock Gains Market Momentum - Stocks Telegraph
ENDRA Life Sciences Advances TAEUS Liver Device Strategy - TipRanks
ENDRA Life Sciences pivots to metabolic health market - Investing.com
ENDRA Life Sciences Inc. (NDRA) reports earnings - Quartz
ENDRA Life Sciences Inc. SEC 10-K Report - TradingView
How ENDRA's AI-Powered Device Could Transform GLP-1 Weight Loss Treatment Monitoring - Stock Titan
ENDRA Slashes Monthly Expenses 37% as TAEUS Liver Device Advances - Stock Titan
ENDRA Life Sciences Inc expected to post a loss of $4.10 a shareEarnings Preview - TradingView
ENDRA Life Sciences (NDRA) Projected to Post Earnings on Thursday - Defense World
ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent - Business Wire
ENDRA Life Sciences stock hits 52-week low at $3.89 amid steep decline - Investing.com Canada
ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland - ACCESS Newswire
Critical Contrast: ENDRA Life Sciences (NASDAQ:NDRA) vs. Gadsden Properties (OTCMKTS:GADS) - Defense World
ENDRA Life Sciences to Participate at Upcoming Investor Conferences - ACCESS Newswire
ENDRA Life Sciences Strengthens Global Intellectual Property Protection with Issuance of Two European Patents Related to its TAEUS Probe - ACCESS Newswire
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue - ACCESS Newswire
Where are the Opportunities in (NDRA) - Stock Traders Daily
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock - MSN
Financial Contrast: NeurAxis (NASDAQ:NRXS) versus ENDRA Life Sciences (NASDAQ:NDRA) - Defense World
(NDRA) On The My Stocks Page - Stock Traders Daily
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.36% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% - MSN
(NDRA) Trading Signals - Stock Traders Daily
Study Highlighting ENDRA Life Sciences TAEUS Technology in Patients with High BMI to be presented at AASLD's The Liver Meeting 2024 - Marketscreener.com
Data I/O And 2 Other Stocks Under $5 Executives Are Buying - MSN
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
(NDRA) Technical Data - Stock Traders Daily
ENDRA Life Sciences Inc trading halted, volatility trading pause - TipRanks
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
ENDRA Life Sciences meets Nasdaq listing standards By Investing.com - Investing.com Australia
ENDRA Life Sciences meets Nasdaq listing standards - Investing.com
Endra Life Sciences regains compliance with Nasdaq - TipRanks
ENDRA Life Sciences Regains Nasdaq Compliance, Clears Path for Strategic Growth | NDRA Stock News - StockTitan
ENDRA Life Sciences Reports Q3 2024 Results and Progress - TipRanks
Post Holdings beats Q4 estimates, issues fiscal 2025 outlook - Investing.com
ENDRA Life Sciences Cuts Operating Costs 52%, Accelerates Clinical Trial Progress | NDRA Stock News - StockTitan
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
NDRA stock touches 52-week low at $5.23 amid sharp annual decline - Investing.com
500: Something went wrong - Investing.com India
ENDRA's TAEUS Breakthrough: Liver Fat Detection in High-BMI Patients Validated for AASLD 2024 | NDRA Stock News - StockTitan
U.S. Stock market: Wolfspeed, ENDRA Life Sciences, and Clear Secure see significant declines with Wolfspeed down 32.10% - Business Upturn
U.S. Stock market: Cardlytics(- 30%0, CommScope (-26%) and Wolfspeed (-5%) among top losers as the market opens - Business Upturn
Turkey hopes for lower US tariffs under Trump, lira rallies - Investing.com
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent - The Bakersfield Californian
ENDRA Life Sciences Secures 17th EU Patent for Revolutionary Surgical Technology | NDRA Stock News - StockTitan
ENDRA Life Sciences announces reverse stock split - Investing.com India
ENDRA Life Sciences announces reverse stock split By Investing.com - Investing.com UK
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):